论文部分内容阅读
自从采用广泛淋巴腺切除的胃癌扩大根治术,和局部或肝叶切除胃癌的肝转移癌以后,进展期胃癌的预后虽然有了一定的改善,但因胃癌浸润到浆膜后脱落的癌细胞种植到腹膜的癌灶或浮游在腹水中的癌细胞,治疗一直不很满意。胃癌术后复发,50％以上是由于癌细胞腹膜播散种植后生长所致。这类种植于腹腔的微癌灶肉限不易发现,无法用手术完全切除,并都在术后三年内复发,且预后极坏。腹腔内人工高热加抗癌药物灌注治疗腹膜种植癌,在动物实验中早已取得成功。而应用到临床还是最近几年才开始的。本文将这个方
Since the radical mastectomy with extensive lymphadenectomy and liver metastases with local or hepatectomy for gastric cancer, although the prognosis of advanced gastric cancer has improved to a certain degree, the cancer cells that have come off due to infiltration of gastric cancer into the serosa have been improved. Cancer treatment in the peritoneal cavity or cancer cells floating in the ascites has not been very satisfactory. After recurrence of gastric cancer, more than 50% is due to the growth of cancer cells after peritoneal dissemination. This type of microcancerous meatus implanted in the abdominal cavity is not easy to detect and can not be completely removed by surgery, and all relapse within three years after surgery, and the prognosis is extremely bad. Intraperitoneal artificial hyperthermia plus anti-cancer drug infusion therapy for peritoneal cancer has long been successful in animal experiments. The application to the clinic was only started in recent years. This article will be this party